Animoca Pauses Currenc Merger as Listing Route Stalls
The pause removes Animoca’s direct Nasdaq route, while Currenc regains freedom to raise capital and both sides retain an option to restart talks.
Every Zipp story tagged #ReverseMerger, newest first.
The pause removes Animoca’s direct Nasdaq route, while Currenc regains freedom to raise capital and both sides retain an option to restart talks.
The failed timeline leaves Animoca pursuing another route to public markets, while Currenc shares gave back some gains in after-hours trading.
The pause leaves Animoca's public-market ambitions intact but removes a planned route, while its audit backlog remains central to any relisting effort.
The deal is a backdoor into US capital markets for a ZEC-treasury miner, and the 60% HeartSciences pop shows public investors are buying the structure, not the medtech business.